Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

977 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A randomized controlled trial on the coloprotective effect of coenzyme Q10 on immune-inflammatory cytokines, oxidative status, antimicrobial peptides, and microRNA-146a expression in patients with mild-to-moderate ulcerative colitis.
Farsi F, Ebrahimi-Daryani N, Golab F, Akbari A, Janani L, Karimi MY, Irandoost P, Alamdari NM, Agah S, Vafa M. Farsi F, et al. Among authors: akbari a. Eur J Nutr. 2021 Sep;60(6):3397-3410. doi: 10.1007/s00394-021-02514-2. Epub 2021 Feb 23. Eur J Nutr. 2021. Retraction in: Eur J Nutr. 2022 Sep;61(6):3313. doi: 10.1007/s00394-022-02949-1 PMID: 33620550 Retracted. Clinical Trial.
Can coenzyme Q10 supplementation effectively reduce human tumour necrosis factor-α and interleukin-6 levels in chronic diseases? Protocol for a systematic review and meta-analysis of randomised controlled trials.
Farsi F, Heshmati J, Janani L, Irandoost P, Mesri Alamdari N, Keshtkar A, Akbari A, Vafa M. Farsi F, et al. Among authors: akbari a. BMJ Open. 2017 Oct 8;7(10):e016841. doi: 10.1136/bmjopen-2017-016841. BMJ Open. 2017. PMID: 28993384 Free PMC article.
Can coenzyme Q10 supplementation effectively reduce human tumor necrosis factor-α and interleukin-6 levels in chronic inflammatory diseases? A systematic review and meta-analysis of randomized controlled trials.
Farsi F, Heshmati J, Keshtkar A, Irandoost P, Alamdari NM, Akbari A, Janani L, Morshedzadeh N, Vafa M. Farsi F, et al. Among authors: akbari a. Pharmacol Res. 2019 Oct;148:104290. doi: 10.1016/j.phrs.2019.104290. Epub 2019 Jun 8. Pharmacol Res. 2019. PMID: 31185284
977 results